chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Muscular weakness
Clinical narrative: transient lower extremity weakness; This case was reported by a consumer via call center representative and described the occurrence of lower extremities weakness of in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. In April 2020, 2 weeks after receiving Shingrix, the patient experienced lower extremities weakness of. On an unknown date, the outcome of the lower extremities weakness of was resolved with sequelae.   It was unknown if the reporter considered the lower extremities weakness of to be related to Shingrix.  Additional details were provided as follows: The reporter was inquiring because he experienced this symptom two weeks out from the second inject of Shingrix. The event occurred around April 2020. The weakness was transient. The reporter asked if there were any reports of transient lower extremity weakness with Shingrix. The reporter personally did not believe if there was a correlation but wanted to see if it had been reported during trials and follow up. The patient was concerned now only because of the possibility of taking the COVID vaccine. The reporter did not consent to follow up.
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, Malaise, Pain in extremity
Clinical narrative: arm was sore; felt fatigued / wanting to stay in bed; not feeling well; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th November 2020, the patient received the 1st dose of Shingrix. On 30th November 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, fatigue and feeling unwell. On 1st December 2020, the outcome of the pain in arm, fatigue and feeling unwell were recovered/resolved.   It was unknown if the reporter considered the pain in arm, fatigue and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for himself. The patient felt fatigued and his arm was sore, he described it as just not feeling well and wanting to stay in bed. The symptoms lasted approximately one day. The reporter consented to follow-up.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site rash
Clinical narrative: Developed pain at the injection site; Small rash at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th November 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced injection site pain and injection site rash. On an unknown date, the outcome of the injection site pain and injection site rash were recovered/resolved.   It was unknown if the reporter considered the injection site pain and injection site rash to be related to Shingrix.  Additional details were reported as follows: The case was reported by patient herself. The patient received the first dose of the shingrix vaccine and developed pain at the injection site accompanied with a small rash at the injection site. Those reactions were resolved.  The patient could not find Healthcare professional's contact information during call, it was not obtained for that reason. The reporter did not consent to follow up. For tolerance of 2nd dose, refer case US2021AMR032873. Discrepancy: Patient's DOB was not captured even though it was not reported.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR032873:Same reporter.
Sex: F
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: Vial was shaken before administering; A spontaneous report was received from a health care professional who was also a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and the vial was shaken before administered / wrong technique in product usage process.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On date unknown, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273, lot # unknown, intramuscularly in for prophylaxis of COVID-19 infection.    On 19 Feb 2021, the patient reported that the vial was shaken before it was administered to her.   No treatment information was provided.     Action taken with mRNA-1273 in response to the events was not reported  The event, vial was shaken before administered, was resolved on unknown date.; Reporter's Comments: This report refers to a case of Wrong technique in product usage process for mRNA-1273, lot # unknown with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Medical facility that gave a 16 year old the vaccine; A spontaneous report was received from a consumer concerning a female patient who received Modern's COVID-19 vaccine (mRNA-1273) at 16-year-old.  The patient's medical history was unknown. Concomitant medication were not reported.  On 14-Jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273, intramuscularly, at left deltoid (lot/batch: unknown) for prophylaxis of COVID-19 infection. No treatment information was provided.   Action taken with mRNA-1273 in response to the event "Inappropriate age at vaccine administration" was not reported.   The outcome of the event "Inappropriate age at vaccine administration" was resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old female) for mRNA-1273 (lot number unknown) with no associated AEs reported.
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: Vaccine administered subcutaneously instead of intramuscularly; A spontaneous report was received from a nurse concerning a 68 year-old, female who received Moderna's COVID-19 Vaccine (mRNA-1273) and the vaccine was administered subcutaneously instead of intramuscularly.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 03-Feb-2021, the patient received their first of two planned doses of mRNA-1273 subcutaneously for prophylaxis of COVID-19 infection.  On 03-Feb-2021, the patient's daughter, who was also a nurse, reported that the patient received her vaccine subcutaneously instead of intramuscularly.  Action taken with mRNA-1273 in response to the event was not reported.   The event, vaccine was administered subcutaneously instead of intramuscularly, was resolved on 03-Feb-2021.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot # unknown) with no associated AEs reported.`
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pediatric patient received the first dose of the Moderna COVID19 vaccine; A spontaneous report, was received from a nurse, concerning a 17 years-old male patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), which resulted in pediatric patient received the first dose of the Moderna COVID19 vaccine (product administered to patient of inappropriate age).   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 19 Feb 2021, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown), for the prophylaxis of COVID-19 infection.   The nurse who was the supervisor for outpatient monitoring reports an adverse event that a pediatric patient received the first dose of the Moderna COVID19 vaccine on 19 Feb 2021. The patient was a 17 years and 2 months old and declines to be contacted further for any further information. No treatment information was provided.   Action taken with second dose of mRNA-1273 in response to the event was not reported.   The outcome of the event, pediatric patient received the first dose of the Moderna COVID19 vaccine, was recovered on 19 Feb 2021.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273, with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: needle tip dislodged; some of the medication ran down the patient's arm, unknown how much of the dose the patient received; A spontaneous report was received from a nurse for a 60 year old white female patient who received Moderna's COVID-19 vaccine (mRNA-1273).   The patient's medical history was not provided. No concomitant product use was reported.  On 02 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection. While the vaccine was being administered the needle tip dislodged and consequentlysome of the medication ran down the patient's arm. The exact dose received by the patient was not reported.  Treatment information was not applicable.  Action taken with mRNA-1273 was not applicable.  The outcome of the events needle tip dislodged and some of the medication ran down the patient's arm, unknown how much of the dose the patient received, was considered as recovered.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Adminstered second dose of vaccine on day 20; A spontaneous report were received from a healthcare professional, concerning a patient of unknown age and gender, who received Moderna's COVID-19 vaccine (mRNA-1273) and administered second dose of vaccine on day 20.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 29 Jan 2021, nurse administered first dose of vaccine to the patient and on 17 Feb 2021 the second dose was administered.  Nurse administered second vaccine to patient on day 20 after 1st Moderna vaccination (Inappropriate schedule of vaccine administered).  Action taken in response to the Inappropriate schedule of vaccine administered was unknown.  The outcome of the event Inappropriate schedule of vaccine administered was unknown.; Reporter's Comments: This case concerns a patient of unknown gender and age who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Inappropriate schedule of vaccine administered without any associated adverse events.; Sender's Comments: 03 Mar 2021: Off label use check box was tick, (as per decription provided in the event section of source document).
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Under 18 year old patient vaccinated; A spontaneous report was received from other health care professional and concerns a 17-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273), characterizing, Under 18 year old patient vaccinated (PT: Product administered to patient of inappropriate age).  The patient's medical history was not provided. The patient was allergic to penicillin.  On 15-FEB-2021, an under 18-year-old patient, received their first of two planned doses of mRNA-1273 (batch number: 031L20A) through an unknown route in an unknown arm for prophylaxis of COVID-19 infection, characterizing Product administered to patient of inappropriate age.  The reporter wanted to know, if the patient could receive his second shot the following month when he will be 18-year-old.   No treatment information was provided.    Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event was considered resolved.; Reporter's Comments: This report refers to a case of 17-year-old male with Product administered to patient of inappropriate age for mRNA-1273, lot # 031L20A with no associated adverse events. Event considered resolved.
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Extra dose administered, Syringe issue, Vaccination site pain
Clinical narrative: syringe broke, so the nurse readministered another entire dose; syringe broke, so the nurse readministered another entire dose; dry mouth; arm extremely sore; A spontaneous report was received from a from a consumer and concerning a 36 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dry mouth and her arm extremely sore.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 21 Jan 2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 lot: 012L20A  intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 9 Feb 2021 prior to the onset of the events, the patient received their second dose of mRNA-1273 lot: D32L20A  intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 19 Feb 2021, The patient experienced the events as dry mouth and her arm extremely sore  Before taking the second dose the syringe broke, so the nurse readministered another entire dose in the same arm (left arm). and she doesn't know if it belongs to both doses or to which dose it belongs to.  Laboratory details not provided.  Treatment details not provided.   Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events dry mouth and her arm extremely sore was unknown and for syringe issue and extra dose administered was considered as recovered.; Reporter's Comments: This case concerns a 36 Y/O F with NS unexpected events of syringe broken and extra dose administered for mRNA-1273 lot # D32L20A, with associated adverse events of NS unexpected dry mouth and NS expected vaccination site pain. Events occurred the same day as second dose mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Incorrect route of product administration, Pain in extremity, Underdose
Clinical narrative: Sore arm; Feels that did not received the full vaccine; The syringe did not enter to the muscle, but entered to the fat; A spontaneous report, was received from a consumer (patient), female adult patient of unknown age, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced sore arm (pain in extremity), feels that did not received the full vaccine (underdose), and the syringe did not enter to the muscle, but entered to the fat (incorrect route of product administration). The patient's medical history was not reported. Concomitant medications were not reported.  On 21 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (lot number: 029L20A), intramuscularly for the prophylaxis of COVID-19 infection.  On 15 Feb 2021, prior to the onset of the events, the patient received their second planned doses of mRNA-1273 (lot number: 004M20A), into the arm for the prophylaxis of COVID-19 infection.  On an unknown date in Feb 2021, the patient experienced sore arm, and feels that did not received the full vaccine. The patient noticed that the nurse who administered her the vaccine squeezed the arm before giving the vaccine, and it seems that the syringe did not enter to the muscle but entered to the fat. The patient states that, between the two doses, took an antibody test, with a negative result. The patient inquires if she can take another antibody test and if she can receive a third dose to ensure more protection. No treatment information was provided.  Action taken with second dose of mRNA-1273 in response to the events was not applicable.  The outcome of the event, sore arm was reported as unknown, that of events feels that did not received the full vaccine, the syringe did not enter to the muscle, but entered to the fat, were considered as recovered on an unknown date in Feb 2021.; Reporter's Comments: This case concerns a female who had nonserious unexpected events of incorrect route of product administration for the second dose of mRNA-1273 (lot # 029L20A) with associated adverse events of underdose and pain in extremity. The adverse events occurred with unknown latency. Events resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose, Wrong product administered
Clinical narrative: Partial dose of 0.3ml as 2nd dose; 1st shot of Pfizer and second shot of Moderna COVID 19 Vaccine; A spontaneous report was received from a other health professional (nurse) concerning a 80-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273), received 1st shot of Pfizer and was given 2nd shot of Moderna COVID vaccine which was partial dose of 0.3ml.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, the patient received the first dose of Pfizer.   On 19 Feb 2021, the patient received their doses of mRNA-1273 (041L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 19 Feb 2021, patient received 1st shot of Pfizer and was given 2nd shot of Moderna COVID vaccine which was partial dose of 0.3ml.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of event patient received 1st shot of Pfizer and was given 2nd shot of Moderna COVID vaccine which was partial dose of 0.3ml was considered resolved.; Reporter's Comments: This report refers to a case of under dose, wrong product administered for mRNA-1273, lot # 041L20A with no associated AEs.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Wrong product administered
Clinical narrative: Partial dose of 0.3ml as 2nd dose; 1st shot of Pfizer and second shot of Moderna COVID 19 Vaccine; A spontaneous report was received from a other health professional (nurse) concerning a 78-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273), received first vaccination of Pfizer vaccine and was given second vaccination of Moderna COVID vaccine which was a partial dose of 0.3ml.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, the patient received the first vaccination dose of Pfizer vaccine.   On 19 Feb 2021, the patient was given a second vaccination dose of mRNA-1273 (041L20A) intramuscularly for prophylaxis of COVID-19 infection, which was a partial dose of 0.3 ml of Moderna COVID vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of event patient received first vaccination of Pfizer and was given a second vaccination of Moderna COVID vaccine which was partial dose of 0.3ml was considered resolved.; Reporter's Comments: This report refers to a case of wrong product administered and accidental underdose for mRNA-1273, lot # 041L20A with no associated AEs.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, Pain in extremity
Clinical narrative: Arm ache; Patient received 3/4 of the dose; A spontaneous report was received from a consumer concerning a 72-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273), received 3/4 of the vaccine and the rest went to the floor and the patient experienced arm ache.  The patient's medical history was not provided. Concomitant medications included Eliquis, unspecified blood pressure medicine and low dose aspirin.  On 20 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273(Batch Number 043L20A), unknown route for prophylaxis of COVID-19 infection.  On 20 Feb 2021, the patient received 3/4 of the vaccine and the rest went to the floor. On an unknown date, the patient experienced arm ache.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event received 3/4 of the vaccine and the rest went to the floor was considered recovered. The outcome of the event arm ache was not reported.; Reporter's Comments: This report refers to a case of accidental underdose for mRNA-1273, lot # 043L20A, with associated adverse event. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Vaccination site extravasation
Clinical narrative: Fluid on her arm (droplet); Didn't receive the entire dose; A spontaneous report, was received from a consumer (patient), a 61 years-old white female patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced fluid on her arm (droplet) (vaccination site extravasation), and didn't receive the entire dose (incorrect dose administered).  The patient's current conditions included hypertension and allergies. Concomitant medications reported included lisinopril and unspecified allergy tablet.   On 09 Feb 2021, prior to the onset of the events, the patient received their second planned doses of mRNA-1273 (lot number: 010M20A), intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 09 Feb 2021, after the vaccination, the patient experienced that there was fluid on arm (droplet), and the nurse wiped it off. The patient stated that the nurse also attempted to place a band aid over the injection area, but the site was moist, and the band aid wouldn't stick. The patient was concerned if she didn't receive the entire dose. No treatment information was provided.  Action taken with second dose of mRNA-1273 in response to the events was not applicable.   The outcome of the event, fluid on her arm (droplet) was unknown, and didn't receive the entire dose was considered as recovered on 09 Feb 2021.; Reporter's Comments: This report refers to a case of a 61-year-old female with Vaccination site extravasation and Incorrect dose administered for the second dose of mRNA-1273 (lot # 010M20A) with no associated adverse events.  Events considered resolved.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine given to 17 year old; A spontaneous report was received from a registered nurse concerning a 17 year old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273).   The patient's medical history was not provided. No concomitant product use was reported.  On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the patient returned for the second dose and the mistake that the vaccine was given to a 17 year old male had come to light. Treatment information was not applicable.  The second dose of mRNA-1273 was discontinued in response to the event.  The outcome of the event was considered resolved on 29 Dec 2020.; Reporter's Comments: This case concerns a 17-year-old male who experienced a nonserious unexpected event of Product administered to patient of inappropriate age for first dose mRNA-1273 (lot # 011J20A)  with no associated adverse events.  The second dose of mRNA-1273 was not administered. Event considered resolved.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza virus test
Clinical narrative: Ended up getting influenza b; Initial information was received on 08-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional (patient).  This case involves a patient (unknown demographics) who ended up getting influenza b (influenza), after received INFLUENZA VACCINE.  The patient's past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  At the time of the event, the patient had ongoing medical history asthma.  It was unknown if the patient had any other medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (batch number and expiry date not reported) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious influenza b (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Relevant laboratory test results included: On an unknown date: Influenza virus test, Result: getting influenza B.  The patient went to emergency room (ER) and got breathing treatments and 3 different medications and a shot but it did not help his asthma. The patient will still get the vaccine every year for 65 and older.   It was unknown if the patient experienced any additional symptoms/events.   The details of medication and reason for taking the medicine was not provided.   It was unknown if there were any other lab data/results available.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: day of shot arm had large red mark around injection site and arm itched shortly after shot.  red rash has not gone away but 8 days later red mark is itchy again and seems raised and a bit sore. Red rash has not gotten bigger but it also never went away.
Age: 100.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: General malaise, acetaminophen was gives every 6 to 8 hours
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: redness/rash around injection site - symptom first noticed on 03/05/21.  No pain or itching.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Skin warm, Swelling
Clinical narrative: red, hot, itchy, and swollen 4in.x4in. on right deltoid
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Developed COVID-19 infection after being fully vaccinated. Lab confirmed Nasopharyngeal PCR test. Reported household exposure of COVID -19 from children and AuPair.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Injection site pain, Musculoskeletal stiffness, Pain
Clinical narrative: Approximately 12 hours after getting the vaccine, I began shivering uncontrollably for about an hour and felt hot (like a fever) at the same time. I also ached all over. I took 2 Tylenol and was able to fall back asleep. I woke up sweaty, but the chills and fever were gone. I?m now just stiff, with some mild pain at the injection site.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Nausea, body aches, headache, fatigue, chills, increased anxiety, sore throat, swollen lymph nodes, wheezing, severe injection site pain.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nausea, Oropharyngeal pain, Pain, Wheezing
Clinical narrative: Nausea, body aches, headache, fatigue, chills, increased anxiety, sore throat, swollen lymph nodes, wheezing, severe injection site pain.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: fever, 100.8, achy, very tired.  Took advil felt better within 24 hours.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Hyperhidrosis, Muscle spasms
Clinical narrative: Body chills, sweating, body aches, nausea, cramps, diarrhea, no appetite
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: Body chills, sweating, body aches, nausea, cramps, diarrhea, no appetite
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Itching, red and swollen rash-like area on the left arm where injection site was. Was fine and nothing there until a few days ago from today's date of 3/5/2021
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Nausea, Pain, Pyrexia
Clinical narrative: Fever, chills, dizziness, nausea, soreness
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Flushing, Headache, Muscular weakness, Pain
Clinical narrative: Headache, extreme fatigue, bright flush but no fever, body aches, muscle tiredness, knot at injection site
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Fatigue, Headache, Injection site pain, Pain
Clinical narrative: I experienced soreness in the injection site immediately following the vaccination and persisting for another two days. Four days following the vaccination (currently ongoing),  I started experiencing body aches, fatigue, a slight headache, and an elevated temperature.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Insomnia
Clinical narrative: Chills, fatigue, sleeplessness
Age: 34.0
Sex: F
Vaccine: UNK
Symptoms: Seizure
Clinical narrative: Seizure
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Injection site hypoaesthesia, Limb discomfort, Pain in extremity
Clinical narrative: Moderna covid-19 vaccine EUA.  Numbness mostly around injection site, tingling and heaviness of entire arm within 5-10 min of injection.  Benedryl was given and symptoms gradually improved within 20-30 minutes. Lightheaded and slight headache next day. Sore arm for 2 days.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Moderna covid-19 vaccine EUA.  Numbness mostly around injection site, tingling and heaviness of entire arm within 5-10 min of injection.  Benedryl was given and symptoms gradually improved within 20-30 minutes. Lightheaded and slight headache next day. Sore arm for 2 days.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Facial discomfort, Impaired quality of life, Magnetic resonance imaging, Pain
Clinical narrative: Trigeminal neuralgia - shooting and aching/hot knife pain in varying parts of right face, teeth, and jaw. Constant pain and additional lightning bolt pain. Difficult to eat, sleep, speak. Carbamazepine helped but needed dose increases and did not completely relieve symptoms. Condition worsened despite it.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin warm, Trigeminal neuralgia
Clinical narrative: Trigeminal neuralgia - shooting and aching/hot knife pain in varying parts of right face, teeth, and jaw. Constant pain and additional lightning bolt pain. Difficult to eat, sleep, speak. Carbamazepine helped but needed dose increases and did not completely relieve symptoms. Condition worsened despite it.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dizziness, Headache, Nausea, Pain
Clinical narrative: Severe headache, dizziness, nausea, fever, body aches, low back pain
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Severe headache, dizziness, nausea, fever, body aches, low back pain
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Pruritus, Rash erythematous, Skin warm
Clinical narrative: Red rash, hard, warm to the touch, itchy. Onset 7 days after vaccine.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Nodule
Clinical narrative: I have a painful knot on the left side of my collarbone.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Oral pustule
Clinical narrative: white puss spots on upper front gum and upper underside of lip. rinsing with Dexamethazone
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Pain, Urinary incontinence
Clinical narrative: Patient received 1st dose 1/28/2021 at 8:30pm.  On 1/29/21 at 4:30 patient experienced headache, urinary incontinence, body ache , dizziness, and chills. Symptoms lasted 24 hours. Second dose administered 3/5/2021
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: Severe body aches all over, painful to move, bad chills resulting in wearing gives, heavy socks and many blankets while lying in bed.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea
Clinical narrative: Menstrual period never came. Not  pregnant. Not sure if it?s related to the vaccine but it usually shows up on time so thought it could be worth reporting.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Mobility decreased, Pain in extremity
Clinical narrative: sore arm, couldn't raise it above my head,  Dizziness for about 50 percent of the day after shot, Small amount of chills.  this is the first covdid-19 injection.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertensive urgency, Injected limb mobility decreased, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: initially patient had no symptoms with Moderna vaccination, no pain worked out at gym in week after shot, initially felt well then started having throbbing severe pain in right deltoid area of arm where vaccine was placed reports no falls, no accidents to this body region noted as well a rash over the area, itchy, 1 week duration, with red vesicles that are now older pain is worsened with palpation of deltoid muscle, acromioclavicular joint and passive abduction and flexion at shoulder and range of motion was limited incidentally patient also had new-onset hypertensive urgency at that time, possibly secondary to pain
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash, Injection site vesicles
Clinical narrative: initially patient had no symptoms with Moderna vaccination, no pain worked out at gym in week after shot, initially felt well then started having throbbing severe pain in right deltoid area of arm where vaccine was placed reports no falls, no accidents to this body region noted as well a rash over the area, itchy, 1 week duration, with red vesicles that are now older pain is worsened with palpation of deltoid muscle, acromioclavicular joint and passive abduction and flexion at shoulder and range of motion was limited incidentally patient also had new-onset hypertensive urgency at that time, possibly secondary to pain
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Cognitive disorder, Fatigue, Headache
Clinical narrative: Fatigue. Impaired cognition. Chills. GI upset. Headaches. Muscle aches.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Fatigue. Impaired cognition. Chills. GI upset. Headaches. Muscle aches.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Itchiness, red and raised skin at site of injection appeared a week after the shot. It lasted about 2 days. Was not major, but was itchy.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Herpes zoster, Myalgia, Neck pain
Clinical narrative: Severe case of shingles in left arm. Electrical shock type pain from left mastoid thru neck, shoulder, arm to palm, thumb and finger tips. Muscular pain from neck (felt like pinched nerve) thru shoulder to wrist (felt like carpel tunnel).  Blooming painful pustule rash from shoulder to wrist on inner arm for one week.  Post-herpetic and muscular pain  continues through rash scabbing and drying, to date March 6, 2021.  This is my second event in 37 years.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pustule, Rash
Clinical narrative: Severe case of shingles in left arm. Electrical shock type pain from left mastoid thru neck, shoulder, arm to palm, thumb and finger tips. Muscular pain from neck (felt like pinched nerve) thru shoulder to wrist (felt like carpel tunnel).  Blooming painful pustule rash from shoulder to wrist on inner arm for one week.  Post-herpetic and muscular pain  continues through rash scabbing and drying, to date March 6, 2021.  This is my second event in 37 years.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling
Clinical narrative: pt described doing fine during initial observation period. She went grocery shopping and within about 3 hours of receiving the vaccine, her eyes swelled "like bugged out" and she had her blood pressure taken at home with a systolic measurement of 214. Someone else in her home checked the functioning of the B/P cuff and theirs measured normally. The patient rechecked hers at that point and it was 200+.  She does not had a history of hypertension and has never been on anti-hypertensives.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Muscle tightness, Musculoskeletal stiffness, Neck pain, Pain
Clinical narrative: Initially ( on the night of 2-26-2021 while taking a shower), I noticed a lump under my left armpit. It was slightly swollen and sore/painful to the touch...after about 3 to 4 days this subsided. On Monday ( March 1, 20201) until the present I have had intense pain at the nap on my neck -it is a stiffness and tightness. It is intermittent and can only be relieved with ibuprofen
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Urticaria
Clinical narrative: Patient developed urticarial rash and some facial swelling. She took oral antihistamines with relief.  She was given cetirizine to take after she was examined the day following her vaccine.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Biliary obstruction, Cholecystitis acute, Cholelithiasis, Gallbladder enlargement
Clinical narrative: Patient with history of TIA one week prior presented to the ED for recent onset of fever and epigastric abdominal pain. Pt found to have calculus of bile duct with acute cholecystitis and obstruction. In Ed pt had fever as high as 104 and pulse as high as 129. The gallbladder was found to be distended  with wall thickening and large gallstone in the lumen. Patient transferred to tertiary care facility.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Pyrexia
Clinical narrative: Patient with history of TIA one week prior presented to the ED for recent onset of fever and epigastric abdominal pain. Pt found to have calculus of bile duct with acute cholecystitis and obstruction. In Ed pt had fever as high as 104 and pulse as high as 129. The gallbladder was found to be distended  with wall thickening and large gallstone in the lumen. Patient transferred to tertiary care facility.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: pt states that after the ninth day after taking the vax she developed a itchy, red, swollen warm 3" rash around the injection site on her right arm.  Pt will contact her PCP regarding her symptoms.no
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Malaise, Pyrexia
Clinical narrative: woke up with fever, chills, joint aches, headache, general malaise
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal wall oedema, Body temperature increased, Cough, Dyspnoea, Oedema peripheral
Clinical narrative: today he presents with complaints of dyspnea at rest, associated with a cough, abdominal and scrotal edema and bilateral leg edema.  He also reports getting his 2nd COVID vaccine yesterday which causes him to have a 102 temperature and worsening cough.  He reports a 30lb weight gain since January.  He was on tikosyn for AF rate control which was recently stopped, but he was unsure why.  He was regularly using CPAP machine, but stopped using about last year due to concerns with coronavirus.  He was previously active going to the gym which she is also stopped during the pandemic due to inaccessibility
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Scrotal oedema, Weight increased
Clinical narrative: today he presents with complaints of dyspnea at rest, associated with a cough, abdominal and scrotal edema and bilateral leg edema.  He also reports getting his 2nd COVID vaccine yesterday which causes him to have a 102 temperature and worsening cough.  He reports a 30lb weight gain since January.  He was on tikosyn for AF rate control which was recently stopped, but he was unsure why.  He was regularly using CPAP machine, but stopped using about last year due to concerns with coronavirus.  He was previously active going to the gym which she is also stopped during the pandemic due to inaccessibility
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site reaction, Urticaria
Clinical narrative: Reaction started approximately at 10:30 AM, broke out with welts all over per patient. Reported being itchy but the welts had subsided quickly (before any medication was administered). No other new foods, detergents, soaps. No previous welts on her skin.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present, Chest pain, Hyperglycaemia
Clinical narrative: midsternal pain, blood in urine, hyperglycemia
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: Exactly one week after receiving the first Moderns vaccine I developed a rash that spread from the vaccine site on my left upper arm. It is itchy and sometimes hurts a bit. I do not know if it will spread but it is exactly what happened after I had the first and second SHINGRIX vaccines in January 2020 and October 2020. I can provide photos of both the Shingrix vaccine reactions (which I reported) and this Moderna vaccine reaction.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Patient felt "a little dizzy" after sitting  for 15 minutes post vaccination. Pharmacist asked for other possible reactions: tingling, itchy skin, rash, difficulty swallowing or swelling of lips. Patient denied all those reactions  stating that he only felt "a little dizzy." He decided that he would sit for 10-15 more minutes to "wait it out." Patient was given water to sip while seated for the extra time. After about 10 minutes he was able to walk without feeling dizzy and reported to the pharmacist that he was well. Pharmacist advised him to log onto the V-Safe site to report his reactions and to review the Moderna EUA.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Genital rash, Rash
Clinical narrative: About a week after the 2nd dose, I started to get a rash on my feet and legs and private areas.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Injection site pain, Injection site pruritus, Rash
Clinical narrative: Face is red with rash, puffy,  burning, and itchy. Itchy at site of injection and arm pain.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Face is red with rash, puffy,  burning, and itchy. Itchy at site of injection and arm pain.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Disorientation, Fatigue, Feeling abnormal, Headache
Clinical narrative: About 20 hours after 1st dose, I started becoming very tired and spacey. 24 hours after dose, I felt very exhausted with a headache behind my eyes and pain in my neck and upper back (felt more skeletal than muscular). I fell asleep for 2 hours and woke up with a headache, some disorientation and feeling slightly nauseated. I had gotten plenty of good sleep the night before these symptoms and hadn't felt any immediate side-effects.  ...I don't feel that these are serious side-effects, but thought maybe the feedback would be worthwhile.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neck pain
Clinical narrative: About 20 hours after 1st dose, I started becoming very tired and spacey. 24 hours after dose, I felt very exhausted with a headache behind my eyes and pain in my neck and upper back (felt more skeletal than muscular). I fell asleep for 2 hours and woke up with a headache, some disorientation and feeling slightly nauseated. I had gotten plenty of good sleep the night before these symptoms and hadn't felt any immediate side-effects.  ...I don't feel that these are serious side-effects, but thought maybe the feedback would be worthwhile.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: Headache, nausea, body aches
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Pregnancy
Clinical narrative: Patient received vaccine at 12:22 pm on 3/4/21 and was initially feeling well. Patient was waiting out her 15 minute observation period and between 10 and 15 minutes after vaccination started feeling warm and like she was going to faint. Patient sat down and elevated her feet, drank water, and used wet cool cloth on face and started feeling better. Patient is approx 12 weeks pregnant.   Checked blood pressure. First reading was 113/72. Second reading was 110/70. Patient stated that this is a normal blood pressure reading for her. Monitored patient for approx 1 hour from time of vaccine. Walked around facility to monitor for any further symptoms upon standing. Patient was asymptomatic after initial episode.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Urticaria
Clinical narrative: On day 7 after the vaccine, I experienced a large knot in my arm near the injection and itching around the area about 1 inch in diameter.  some raised skin around the injection was also noticed, like hives.  No other side effects were noticed with this development.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Fatigue, Feeling abnormal, Head discomfort
Clinical narrative: Light headed, dizziness, fatigue, word finding problems, confusion, "brain fog", headache, head pressure, tingling
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Paraesthesia
Clinical narrative: Light headed, dizziness, fatigue, word finding problems, confusion, "brain fog", headache, head pressure, tingling
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Coronary artery disease, Electrocardiogram, Heart rate abnormal, Hyperhidrosis, Tachycardia
Clinical narrative: pt was given first dose of covid vaccine moderna, she developed tachycardia, pvc's, and sweaty . pt with history of non obstructive cad, pt was transported to ER and discharged in stable condition
Age: 59.0
Sex: F
Vaccine: UNK
Symptoms: Abdominal pain upper, Chills, Headache, Nausea, Pyrexia
Clinical narrative: On first injection (3 months ago) I only experienced extreme soreness in the arm. With this injections, I developed a fever of over 101, chills, headache, nausea and stomach pain within 12 hours of receiving the vaccine at 9:30 am.  The fever and other symptoms had diminished by 8 am the following morning with acetaminophen.  All symptoms, without additional medication, appear to have been within 48 hours.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: My husband also had the same vaccine at the same time but did not experience my symptoms as described below: Vaccination was given very high on the should blade instead of upper arm of left arm. After the injection on 2/27/21 arm was mildly sore, but on the third day, there was more pain. On March 3, the pain was worse, very painful to lift or bend left arm, constant throbbing pain, there is no inflammation on the injection site but whole left arm especially the injection site is very very painful. To this day, March 5, 2021 the pain and throbbing persists, It is very painful to lift or bend the left arm. Will start take OTC CVS Ibuprofen 200 mg every 6 hours to ease the pain.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Blood creatine, Blood potassium, Cough
Clinical narrative: 24 hours after vaccine given fever of 102  chills, loss of appetite body aches head ache cough loss of taste and smell extreme tiredness. Lasting    8 days with  cough still present. Took Tylenol, doctor did a Covid test with negative results. I had Covid 19 previously in November 2020 with  same symptoms lasting 14 days
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Full blood count, Headache, Pain, Pyrexia
Clinical narrative: 24 hours after vaccine given fever of 102  chills, loss of appetite body aches head ache cough loss of taste and smell extreme tiredness. Lasting    8 days with  cough still present. Took Tylenol, doctor did a Covid test with negative results. I had Covid 19 previously in November 2020 with  same symptoms lasting 14 days